AYA Cancer Survivors

Research in countries other than France has documented poor gynaecological follow-up adherence among cancer survivors, driven by fear of re-diagnosis, a wish to move on from illness, and absence of perceived need. The most common cancer type in the exposed cohort was thyroid cancer at 21.2%, followed by Hodgkin lymphoma at 19%. In France, approximately 2,150 adolescent and young adults are newly diagnosed with cancer each year, more than half of whom are female. Haematological malignancies were disproportionately common in the 15–19 age subgroup, accounting for 37.8% of cases. AYA cancer survivors face elevated gynaecological risks including increased exposure to STIs and HPV, treatment-induced endocrine dysfunction, fertility impairment, and heightened susceptibility to cervical dysplasia.